Analyst Research: Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

10.23USD
1 Aug 2013
Price Change (% chg)

$0.06 (+0.59%)
Prev Close
$10.17
Open
$10.46
Day's High
$10.68
Day's Low
$10.11
Volume
101,040
Avg. Vol
84,065
52-wk High
$10.68
52-wk Low
$3.90

Search Stocks
Name Age Since Current Position

Karen Dawes

60 2011 Independent Chairman of the Board

Alexander Rich

87 2011 Independent Chairperson Emeritus of the Board

Walter Herlihy

60 1996 President, Chief Executive Officer, Director

Jonathan Lieber

40 2012 Chief Financial Officer, Treasurer, Principal Financial Officer

Michael Hall

50 2011 Chief Medical Officer and Senior Vice President - Clinical and Regulatory Affairs
Search Stocks